Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order.
View exclusive Global strategic Business report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2014 to 2020, considering 2013 as the base year.
In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on the surgery types. The segment is categorized into carotid endarterectomy, angioplasty and endovascular mechanical thrombectomy. The market for these surgeries of acute ischemic stroke treatment has been extensively analyzed based on number of surgeries performed and cost of surgery. The market size and forecast in terms of USD million for each segment has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2013 as the base year.
Geographically, the acute ischemic stroke diagnosis and treatment market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global acute ischemic stroke diagnosis and treatment market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2013 in the acute ischemic stroke diagnosis and treatment market.
This research report also explains about value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, patient). One event impact analysis chart is also includes in this report that describe event and their impact associated with this market from 2012 to 2020.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report concludes with the profiles of major players in the acute ischemic stroke diagnosis and treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Covidien plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Hitachi Medical Corporation, GE healthcare, Penumbra, Inc. and Philips Healthcare.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453